Mebeverine
Indications
Registered South African indications:
- Irritable colon secondary to organic lesions and inflammatory conditions of the gastrointestinal tract
- Irritable bowel syndrome
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
Cautions
- Pregnancy
- Breastfeeding
- Galactose intolerance
- Lapp lactase deficiency
- Glucose-galactose malabsorption
- Fructose intolerance
- Sucrase-isomaltase insufficiency
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Irritable bowel syndrome
Irritable colon secondary to organic lesions and inflammatory conditions of the gastrointestinal tract
- Oral (tab): 135mg, 8hrly
Dose should be taken 20min before meals
If one or more doses are missed, the patient should continue with the next dose as prescribed, the missed dose(s) should not be taken in addition to the regular dose
Paediatric dosage
Not established for use in children below 18 years
Special populations
Pregnancy
- Caution
- There are no or limited amounts of data from the use of mebeverine in pregnant women. Animal studies are insufficient with respect to reproductive toxicity. Mebeverine is not recommended during pregnancy
Breastfeeding
- Caution; not recommended
- It is unknown whether mebeverine or its metabolites are excreted in human milk. The excretion of mebeverine in milk has not been studied in animals. Mebeverine should not be used during breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Skin and Subcutaneous Tissue Disorders
- Urticaria
- Angioedema
- Facial oedema
- Exanthema
Immune, Blood and Lymphatic System Disorders
- Anaphylactic reactions
Interactions
No information available
Monitoring
None routine
Mechanism of action
Mebeverine is a musculotropic antispasmodic. It acts directly on the smooth muscle of the gastrointestinal tract, without affecting normal gut motility. Mechanisms of action involve a decrease in ion channel permeabilities, blockade of noradrenaline reuptake, a local anesthetic effect, changes in water absorption, antimuscarinic activity, and a phosphodiesterase inhibitory effect.
Dosage forms
- Tablet
Formulation
Tablet 135mg
- Bevispas (Pharmacare)
- Colofac (Abbott) originator
- Mylan Mebeverine (Mylan)
- Sandoz Mebeverine (Sandoz)
References
1. SAMF_12th Edition_Page 46 2. https://www.medicines.org.uk/emc/medicine/2067 (26/08/2016_Mylan_Colofac_135mg_tab) 3. https://drive.google.com/drive/folders/1jC3j24pp6aEK6yG5N1MaEW5xX_hJ0p3F (2/12/1994_Pharmacare_Bevispas_tab) 4. NAPOS The Drug Database for Acute Porphyria: A03AA04 Mebeverine; Accessed online 13 Dec 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=A03AA04] 5. South African Institute for Drug-Free Sport; Bevispas; Accessed online 13 Dec 2018 [http://www.drugfreesport.org.za/online-medication-check/] 6. SmPC: Mebeverine hydrochloride 135mg film-coated tablets, Aspire Pharma Ltd: Last updated on eMC: 21 Dec 2018; Downloaded online 17 Jan 2019 [https://www.medicines.org.uk/emc/product/9751/smpc]
Brands & products
9 products · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days oldtabletGeneric· 9 products
from R3.28/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Sandoz Mebeverine Hcl 135 | 135 mg | 100 | S2 | R328.27 | R3.28 | R115.52 | 825328012 |
| Mebestend | 135 mg | 100 | S2 | R339.76 | R3.40 | R118.68 | 701892006 |
| Bevispas | 135 mg | 100 | S2 | R345.15 | R3.45 | R120.16 | 822019019 |
| Mebestend | 135 mg | 30 | S2 | R119.61 | R3.99 | R53.27 | 701892010 |
| Sandoz mebeverine | 135 mg | 20 | S2 | R83.21 | R4.16 | R40.67 | 825328004 |
| Mebestend | 135 mg | 20 | S2 | R85.79 | R4.29 | R41.57 | 701892003 |
| Bevispas | 135 mg | 20 | S2 | R86.95 | R4.35 | R41.97 | 822019035 |
| Colofac | 135 mg | 100 | S2 | R629.11 | R6.29 | R177.01 | 715476017 |
| Colofac | 135 mg | 20 | S2 | R156.42 | R7.82 | R66.00 | 715476009 |
- Colofac
- Bevispas
- Mylan Mebeverine
- Sandoz Mebeverine Hydrochloride
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.